Top Story

New model predicts HCV progression, liver-related events

New model predicts HCV progression, liver-related events
May 22, 2015

A risk prediction model developed by researchers from University of Michigan Health System, helped identify which patients with hepatitis C virus infection have the most urgent need for new anti-viral treatment, according to newly published data in Hepatology.

“Offering immediate treatment to patients identified as high risk for poor health outcomes would allow these patients to benefit from highly effective treatments as other patients continue to be monitored and their risk assessment updated at each clinic visit,” Monica Konerman, MD, MSc, gastroenterology fellow at the University of Michigan Health System, said in a press release.

Foundation aims to assist HCV patients with therapy costs

May 22, 2015
The HealthWell Foundation announced the launch of a new fund aimed to assist people living with hepatitis C virus infection who are underinsured, according to a news…

Exviera, Viekirax combination added benefit for patients with HCV without cirrhosis

May 21, 2015
In a manufacturer dossier assessment conducted by the Institute for Quality and Efficiency in Health Care in Germany, Exviera when used in combination with Viekirax was…

Foundation collaborates with Walgreens to launch free HCV testing campaign

May 19, 2015
The Chronic Liver Disease Foundation announced today that in collaboration with Walgreens, it will be offering free hepatitis C virus infection testing via the OraQuick…
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Meeting News Coverage Video
thumbnail for video 3899432251001

New HCV treatments could reduce mortality, but increase costs by billions

November 19, 2014
BOSTON – In this video exclusive from The Liver Meeting, David B. Rein, PhD, MPA, of the National Opinion…
More »
New model predicts HCV progression, liver-related events In the Journals

New model predicts HCV progression, liver-related events

May 22, 2015
A risk prediction model developed by researchers from University of Michigan Health System, helped identify which patients with hepatitis C virus…

Foundation aims to assist HCV patients with therapy costs

May 22, 2015
The HealthWell Foundation announced the launch of a new fund aimed to assist people living with hepatitis C virus infection who are underinsured…

Exviera, Viekirax combination added benefit for patients with HCV without cirrhosis

May 21, 2015
In a manufacturer dossier assessment conducted by the Institute for Quality and Efficiency in Health Care in Germany, Exviera when used in…

Foundation collaborates with Walgreens to launch free HCV testing campaign

May 19, 2015
The Chronic Liver Disease Foundation announced today that in collaboration with Walgreens, it will be offering free hepatitis C virus infection…
Delaying HCV therapy worsens treatment efficacy Meeting News Coverage

Delaying HCV therapy worsens treatment efficacy

May 18, 2015
VIENNA — Delaying treatment for hepatitis C virus infection until an increased fibrosis-4 score is reached negatively impacted the efficacy of…

CDC reminds providers, public Hepatitis Testing Day is May 19

May 18, 2015
May 19 is the fourth annual National Hepatitis Testing Day and the Centers for Disease Control and Prevention want to remind health care providers…
In the Journals

Oxidized LDL predicts SVR after interferon-based therapy for HCV

May 15, 2015
Oxidized low-density lipoprotein accurately predicted a patient’s response to interferon-based therapy for hepatitis C virus infection…

WHO releases 2015 essential medicines list, including HCV drugs

May 14, 2015
The World Health Organization has released the 2015 edition of its Model List of Essential Medicines, which includes the newest treatments for…
HCV increases mortality among patients with CKD In the Journals

HCV increases mortality among patients with CKD

May 12, 2015
Veterans with chronic kidney disease and hepatitis C virus infection were found to have an increased rate of mortality, risk of lower kidney function…
In the Journals

Diabetes increases risk for HCC in adults with HBV

May 12, 2015
Taiwanese patients with chronic hepatitis B virus infection and newly diagnosed diabetes had an increased risk for hepatocellular carcinoma over…
More Headlines »